Editas Medicine (EDIT) Revenue Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) Revenue Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 50.07% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 79.44% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 464.20% |
| Jun 30, 2025 | -17.46% |
| Mar 31, 2025 | -11.72% |
| Dec 31, 2024 | 34.89% |
| Sep 30, 2024 | -78.57% |
| Jun 30, 2024 | 10.62% |
| Mar 31, 2024 | -44.10% |
| Dec 31, 2023 | 73.90% |
| Sep 30, 2023 | -56.05% |
| Jun 30, 2023 | -35.48% |
| Mar 31, 2023 | 19.84% |
| Dec 31, 2022 | -18.97% |
| Sep 30, 2022 | -77.82% |
| Jun 30, 2022 | 39.77% |
| Mar 31, 2022 | 48.47% |
| Dec 31, 2021 | 26.78% |
| Sep 30, 2021 | -24.71% |
| Jun 30, 2021 | -62.82% |
| Mar 31, 2021 | 18.28% |
| Dec 31, 2020 | 9.07% |